Background We performed a multistage genome-wide association study of Vogt–Koyanagi–Harada (VKH) syndrome in a Han Chinese population and identified two novel non-human leukocyte antigen candidate regions previously. The aim of the study was to replicate the association of IL23R-C1orf141 and ADO-ZNF365-EGR2 with VKH syndrome in four sets of multinational populations in Asia.
Method We conducted a candidate genes association study involving 185 patients with VKH syndrome and 287 normal controls from Han Chinese Singaporeans, non-Han Chinese, Thais and Koreans. Genotyping of 16 single nucleotide polymorphisms (SNPs) within IL23R-C1orf141 and ADO-ZNF365-EGR2 loci was performed using the Sequenom MassARRAY system or by Taqman SNP assays.
Results Eight SNPs in IL23R-Clorf141 showed an association with VKH syndrome only in Han Chinese Singaporeans (p=8.49×10−5 to 1.02×10−3, pcorrection=1.69×10−4 to 2.04×10−3) but not in the other groups tested. One SNP rs1884444 in IL23R-Clorf141 was found to be weakly associated with VKH syndrome in the Han Chinese Singaporeans, but significance was lost following Bonferroni correction for multiple comparisons. Five SNPs in ADO-ZNF365-EGR2 were found to be associated with VKH syndrome in Thai patients with VKH (p=0.014, pc=0.028) but not in the other three ethnic groups tested.
Conclusions This study confirmed the genetic associations between SNPs in IL23R-C1orf141 and VKH syndrome in Han Chinese Singaporeans but not in other Asian populations. In addition, we also successfully replicated the association of VKH syndrome with ADO-ZNF365-EGR2 in a Thai population.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Vogt–Koyanagi–Harada (VKH) syndrome is a multisystemic autoimmune disorder characterised by bilateral granulomatous panuveitis frequently associated with alopecia, vitiligo, poliosis and central nervous system and auditory signs.1 ,2 It frequently affects certain ethnic populations, such as Chinese, Japanese and native Americans.3 It is one of the most common seen and severe sight-threatening uveitis entities in China. Although the precise aetiology and pathogenesis of VKH syndrome remains unknown, numerous studies have shown an association between HLA-DR4 and HLA-DR53 with VKH syndrome in various ethnic populations.4–6 Additionally, a variety of non-human leukocyte antigen (HLA) genes including CTLA-4, MIF, MCP-1, IL23A and C4A were found to be associated with VKH syndrome.7–11
Recently, we performed the first multistage genome-wide association study (GWAS) of VKH syndrome in a Han Chinese population to investigate additional genetic variants, and identified two novel non-HLA candidate regions.12 These candidate loci include several genes such as IL23R-C1orf141 and ADO-ZNF365-EGR2. However, the association was only tested in Han Chinese and has not yet been confirmed in other ethnic populations. We therefore decided to repeat our study in a multinational project including Han Chinese Singaporeans from Singapore, non-Han Chinese patients with VKH from South-West China, Thais from Thailand and Koreans from South Korea.
A total of 16 single nucleotide polymorphisms (SNPs) in the two new loci including IL23R-C1orf141 at 1p31.2 and ADO-ZNF365-EGR2 at 10q21.3 were genotyped to investigate the association between the identified risk genes/loci and VKH syndrome in these other ethnic populations. The study confirmed our earlier findings and showed that IL23R-C1orf141 was associated with Han Chinese Singaporeans but not in other Asian populations. In addition, we also found the association between ADO-ZNF365-EGR2 with VKH syndrome in Thais.
Recruitment of patients and normal controls
One hundred eighty-five patients with VKH syndrome and 287 normal controls were recruited for this project. The first set included 32 Han Chinese Singaporean patients with VKH and 94 controls from Singapore. These were generally the descendants of immigrants from the South-Eastern coast of China in the provinces of Fujian and Guangdong during the 19th and early half of the 20th century. The second set included 38 patients and 60 controls from a non-Han Chinese ethnic population from South-West China. China is a united multiethnic country since ancient times. Fifty-five ethnic groups other than the Han population are referred to as minorities and include ethnic groups such as Manchu, Mongolian, Hui, Tibetan, Uygur, Kazak, Miao, Yi and Zhuang. The third set included 81 patients and 33 controls from Thailand. The last set included 34 Korean patients with VKH and 100 healthy controls. All patients strictly fulfilled the First International Workshop criteria for VKH syndrome.13 Cases were excluded from the study if the diagnosis was uncertain. All cases were diagnosed by senior ophthalmologists. DNA was extracted from peripheral blood using standard techniques as described below. The study protocols were approved by the Clinical Research Ethics Committee of the First Affiliated Hospital of Chongqing Medical University, Singapore National Eye Centre, Ramathibodi Hospital, Bangkok and Sensory Organs Institute, Medical Research Center, Seoul. All procedures followed the tenets of the Declaration of Helsinki and informed written consent was obtained from every participant. All experiments were performed in accordance with the approved guidelines and regulations.
To increase the reliability of the results, 16 SNPs were chosen as candidates. SNPs enrolled in this study within the IL23R-C1orf141 and ADO-ZNF365-EGR2 loci showed strong genetic associations with VKH syndrome in our earlier GWAS. These SNPs are located within the gene IL23R-C1orf141 on chromosome 1p31.2 including rs77258390, rs3762318, rs78597810, rs12568393, rs12561798, rs76436269, rs78377598, rs117633859, rs1884444 (these nine SNPs are located in the same linkage disequilibrium (LD) block) (figure 1) and SNPs located within the gene ADO-ZNF365-EGR2 on chromosome 10q21.3 including rs10995276, rs442309, rs224048, rs224052, rs224057, rs224058 and rs10995307 (these seven SNPs are located in the same LD block) (figure 2). LD block was estimated and showed that the selected SNPs were in strong LD (IL23R-C1orf141 r2=0.92–0.95 and ADO-ZNF365-EGR2 r2=0.76–0.92) (figures 1 and 2). As these SNPs are located in two loci, the p value of Bonferroni correction (pc) is corrected by multiplication with n=2.
DNA extraction and SNP genotyping
Genomic DNA samples were extracted from the peripheral blood of patients with VKH syndrome and healthy controls using QIAGEN QIAamp DNA Mini Blood Kit (Hilden, Germany) according to the manufacturer's instructions. Fifteen SNPs, except rs117633859, were performed using the Sequenom MassARRAY system (Sequenom) according to the manufacturer's instructions. DNA samples were genotyped using TaqMan SNP genotyping assays for rs117633859 (assay ID: AHVJKBP; Applied Biosystems, Foster City, California, USA) on the Applied Biosystems 7500 Real-Time PCR System according to the manufacturer's instructions.
The real-time PCR data were analysed by manufacturer supplied software, V2.0.6 (Applied Biosystems, Foster City, California, USA). The χ2 test was applied for the evaluation of the Hardy–Weinberg equilibrium. Genotype frequencies were estimated by direct counting. The χ2 test or Fisher's exact test using SPSS V.17.0 (SPSS, Chicago, Illinois, USA) was used for the comparison of genotype and allele frequencies between patients and healthy controls. ORs and 95% CIs were calculated using SPSS V.17.0 to estimate disease risk. LD was measured with Haploview V.4.0. A Bonferroni correction was applied to correct for multiple comparisons and a statistical significant difference was considered with a pc value ≤0.05. A power analysis was performed using the Quanto software to verify the association between VKH syndrome and the tested SNPs.
The study was performed using 185 patients and 287 controls. The detailed clinical findings of patients with VKH and controls are summarised in tables 1 and 2.
We had previously reported two new non-HLA susceptibility loci for VKH syndrome including IL23R-C1orf141 at 1p31.2 and ADO-ZNF365-EGR2 at 10q21.3 in Han Chinese using a GWAS approach.12 In the current study, we genotyped 16 SNPs with the two loci associated with VKH syndrome in patients and controls originating from four different multiethnic Asian populations to confirm the association of these two loci with this disease.
Association of the nine gene polymorphisms with susceptibility to VKH syndrome of IL23R-C1orf141 at 1p31.2
Nine SNPs in IL23R-C1orf141 at the 1p31.2 locus, that is, rs77258390, rs3762318, rs78597810, rs12568393, rs12561798, rs76436269, rs78377598, rs117633859 and rs1884444 were genotyped in Han Chinese Singaporeans, non-Han Chinese, Thais and Korean patients with VKH. Our results showed that eight out of nine SNPs in IL23R-C1orf141 showed an association with VKH syndrome in Han Chinese Singaporeans (p=8.49×10−5 to 1.02×10−3, pcorrection=1.69×10−4 to 2.04×10−3) (table 3). A stratification analysis study on gender showed a significant association for several SNPs of IL23R-C1orf141 in Han Chinese Singaporean males (pc=6.4×10−4 to 2.0×10−3) but not in females (see online supplementary table S1).
Replication of suggestive associations (p=0.028 to 0.056, pcorrection=0.056 to 0.112) was sought in 38 non-Han Chinese descent participants with VKH and 60 healthy controls, but significance was lost following Bonferroni correction for multiple comparisons. No association was found for IL23R-C1orf141 and VKH syndrome in the Korean or Thai group (table 3).
Association of the seven gene polymorphisms with susceptibility to VKH syndrome of ADO-ZNF365-EGR2 at 10q21.3
ADO-ZNF365-EGR2 has been identified as a risk factor for VKH syndrome in a Han Chinese population.12 The seven candidate SNPs, including rs10995276, rs442309, rs224048, rs224052, rs224057, rs224058 and rs10995307, were genotyped in Han Chinese Singaporeans, non-Han Chinese, Thai and Korean patients (185 patients and 287 controls). The results revealed that five SNPs in ADO-ZNF365-EGR2 were found to be associated with VKH syndrome in the Thai patients following Bonferroni correction (p=0.014, pc=0.028). Nevertheless, the results revealed that these candidate SNPs in ADO-ZNF365-EGR2 were not associated with VKH syndrome in the other three ethnic populations tested (table 3). As shown in online supplementary table S1, the suggestive association was lost in both male and female Thai patients after performing a stratified analysis by gender.
In this study, the reported association of IL23R-C1orf141 at 1p31.2 with VKH in Chinese Han, as shown in our earlier GWAS,12 was confirmed in Han Chinese Singaporean patients with VKH, but could not be replicated in patients from South-West non-Han Chinese, Korea or Thailand. Furthermore, the study replicated the association with VKH syndrome and ADO-ZNF365-EGR2 in a Thai population but failed to replicate the association in the other three sets of Asian patients.
Variants within the IL23R gene have been reported to be associated with chronic inflammatory diseases, such as ankylosing spondylitis, psoriasis, inflammatory bowel disease (IBD) and Behcet's disease.14–17 IL23R has also been found to be involved in the development of ankylosing spondylitis in Iranian and Chinese Han patients.18–20 A report from Japan suggested that the IL23R gene was associated with autoimmune thyroid diseases (AITDs), but that this was restricted to a specific ethnic group.21 Previous studies have shown a stronger association of IL23R with Behcet’s disease in patients from Turkey22 as compared with cases from Algeria.23 Two SNPs located in the second haplotype block of the IL23R gene showed a marginal association with the risk of polyarticular psoriatic arthritis (p=0.05) in a Romanian case–control cohort.24 Why patients from Han Chinese descent show an association with IL23R-C1orf141 with VKH syndrome whereas other Asian populations do not is not yet clear. Although the clinical features of the patients included in our study are generally similar, it is possible that VKH in non-Han Asian patients may represent a subentity of VKH syndrome. It is also possible that the association with IL23R-C1orf141 is weaker in the other non-Han Asian populations tested and that the sample size was too small to obtain statistically significant findings. Larger sample sizes are needed to address this explanation due to the power value of less than 80%. A gender-based stratification analysis of the IL23R-C1orf141 association with VKH showed a significant effect in male Han Chinese Singaporeans but not in the female population, which suggests that IL23R-C1orf141 may have a gender skewed impact on VKH in Han Chinese Singaporeans. We found that five SNPs on IL23R-C1orf141, including SNP rs3762318, rs12568393, rs78377598, rs117633859 and rs1884444, showed no significant association with VKH in the overall non-Han Chinese group. However, these five SNPs did show a significant difference in females (pc=0.02 to 0.04) (see online supplementary table S1). It should be noted that the statistical power of the gender analysis was low and should therefore be interpreted cautiously (see online supplementary table S2).
The study replicated the association with VKH syndrome and ADO-ZNF365-EGR2 in a Thai population but failed to replicate the association in the other three sets of Asian patients. Previous studies showed that genetic polymorphisms of ZNF365 are associated with immune-related diseases in both Asia and Latin America.25 ,26 ZNF365 was reported to be associated with atopic dermatitis in a Japanese population.25 Variants of ZNF365 have also been identified to be associated with susceptibility to breast cancer.27 Associations were observed with SNPs in the ZNF365 gene and breast cancer risk in Korean women and other ethnic populations.27–34 An Italian cohort showed an association with IBD both in adult and paediatric cohort of patients, with a small influence on subphenotypes.35 Allelic association analysis (two tailed) showed that ZNF365 was significantly associated with overall susceptibility for Crohn’s disease in Canadian children.26 The Oregon Sudden Unexpected Death Study (Oregon-SUDS) suggested that the ZNF365 region contains relevant candidate genes for sudden cardiac death.36 The early growth response gene-2 (EGR2) was characteristically expressed by the iTregs, which played a major role in controlling immune responses.37 Moreover, in the Thai group, ADO-ZNF365-EGR2 showed a significant association with VKH while this was lost after performing a gender-based stratified analysis. The inconsistent result may due to the significant gender frequencies between patients and controls and the low statistical power of the comparisons (see online supplementary table S2).
The various pathogenesis and mechanism behind many ethnic groups base on the interaction of genes and environment. The difference of the associations among the nationalities may be partly explained by the population genetic heterogeneity. Hapmap data shows that the frequencies of SNPs in IL23R-C1orf141 and ADO-ZNF365-EGR2 are different between CEU (Utah residents with Northern and Western European ancestry from the Centre d'Etude du Polymorphisme Humain collection) and CHB (Han Chinese in Beijing) (see online supplementary table S3). Large size of samples is need to be collect in confirming study of European population on these two loci in our study. In addition to the SNPs we selected, another SNPs in IL23R-C1orf141 and ADO-ZNF365-EGR2 may inflict pathogenesis and mechanism of VKH syndrome in CEU patients.
The power value of 0.85–0.94 for SNPs on IL23R-C1orf141 showed the results reality of Han Chinese Singaporeans using a prevalence of VKH syndrome in Asian population of 0.001% represented by the prevalence of Japanese38 because there was no other report of Asian population of VKH syndrome before (table 4). Especially, no risk was observed in ADO-ZNF365-EGR2 in Han Chinese Singaporeans, which suggests that this study may lack power due to small sample size. We only collected samples from descendants of immigrants from the South-Eastern coast of China in the provinces of Fujian and Guangdong. However, the previous GWAS study included Han Chinese cohorts who not only originated from the Fujian and Guangdong Han population, but also included Han Chinese patients from other parts of China. The differences between the cohorts may partially explain the different results concerning ADO-ZNF365-EGR2. Additionally, the minor allele frequency of Han Chinese Singaporean on ADO-ZNF365-EGR2 in Han Chinese Singaporean in the replication study did not reveal an association with VKH syndrome which may be due to the low statistical power of the comparison (power value 0.09–0.18; see online supplementary table S2) and a small size of samples used in this study. Concerning the validation study among non-Han Chinese, the small size of the tested samples might explain the false negative association results (power value 0.28–0.61) (see online supplementary table S2) even though the allele frequencies of IL23R-C1orf141 in non-Han Chinese were higher than in the other groups (table 3). Further studies using a large size of samples from these populations are expected to validate our previous GWAS results.
It is worthwhile to point out that several possible limitations of the present study merit particular consideration. First, further research should be done to correlate the IL23R-C1orf141 and ADO-ZNF365-EGR2 gene polymorphisms with VKH syndrome in other populations in Asia to confirm the results. Furthermore, we have focused on common genetic variants and it is possible that the analysis of rare variants may provide further clues concerning the exact role of these genes in the pathogenesis of VKH syndrome. As suggested above, it is possible that the clinical features among patients from different Asian countries might represent subentities of the disease. Although we tried to match the controls for gender, there were significant gender differences with the groups of Han Chinese Singaporeans, non-Han Chinese and Thai patients with VKH. The statistical power of our study may be low due to the relatively small sample size and the results presented here therefore need to be confirmed in larger samples. Third, although molecular biological studies provide evidence for a role of IL23R polymorphisms, this result is suggestive and does not exactly explain how the genetic variant translates into physiologic processes and disease pathogenesis. Therefore, the association results presented here should be investigated further using functional experiments.
In summary, we confirmed the genetic associations between VKH syndrome and IL23R-C1orf141 in Han Chinese Singaporeans but not in non-Han Asian patients. In addition, we also successfully replicated the association with VKH syndrome and ADO-ZNF365-EGR2 in Thai patients with VKH.
We thank the individuals, their families and friends who participated in this project.
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online supplement
SC, SPC and HGY have contributed equally.
Contributors SC and SH conceived and designed the experiments. PY, SPC, HGY and SS recruited subjects and participated in the diagnostic evaluations. LW, SC and SH performed the experiments and acquired the data. SC, SH, AK and PY analysed the data and drafted the manuscript. AK, SPC, HGY and SS helped revise the manuscript. All authors reviewed the manuscript.
Funding This work was supported by Natural Science Foundation Major International (Regional) Joint Research Project (81320108009), Key Project of Natural Science Foundation (81130019), National Natural Science Foundation Project (31370893, 81270990, 81522013), Research Fund for the Doctoral Program of Higher Education of China (20115503110002), Clinic Key Project of Ministry of Health (201002019), Basic Research Program of Chongqing (cstc2013jcyjC10001), Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), National Key Clinical Specialties Construction Program of China, Key Project of Health Bureau of Chongqing (2012-1-003), Chongqing Science & Technology Platform and Base Construction Program (cstc2014pt-sy10002), and Fund for PAR-EU Scholars Program Chongqing Outstanding Youth Grant (cstc2014jcyjjq10005).
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement I would like to declare on behalf of my coauthors that the work described was original research that has not been published previously, in whole or in part. All the authors listed have approved the manuscript that is enclosed.